Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.86 USD | +0.57% | -0.57% | -23.72% |
Financials (USD)
Sales 2024 * | 26.32M | Sales 2025 * | 155M | Capitalization | 2.08B |
---|---|---|---|---|---|
Net income 2024 * | -260M | Net income 2025 * | -219M | EV / Sales 2024 * | 71.5 x |
Net cash position 2024 * | 193M | Net cash position 2025 * | 111M | EV / Sales 2025 * | 12.7 x |
P/E ratio 2024 * |
-8.44
x | P/E ratio 2025 * |
-10.4
x | Employees | 268 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.58% |
Latest transcript on Rocket Pharmaceuticals, Inc.
1 day | +0.57% | ||
1 week | -0.57% | ||
Current month | +7.22% | ||
1 month | -1.00% | ||
3 months | -18.82% | ||
6 months | -15.21% | ||
Current year | -23.72% |
Managers | Title | Age | Since |
---|---|---|---|
Gaurav D. Shah
CEO | Chief Executive Officer | 49 | 18-01-03 |
Kinnari Patel
PSD | President | 45 | 18-01-03 |
Chief Tech/Sci/R&D Officer | 60 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pedro Granadillo
BRD | Director/Board Member | 77 | 18-01-03 |
Carsten Boess
BRD | Director/Board Member | 57 | 15-12-31 |
David Southwell
BRD | Director/Board Member | 63 | 14-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 2 M€ | -.--% | ||
0.13% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.06% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-13 | 22.86 | +0.57% | 339,952 |
24-06-12 | 22.73 | -0.79% | 1,484,378 |
24-06-11 | 22.91 | +2.51% | 492,440 |
24-06-10 | 22.35 | -1.46% | 775,532 |
24-06-07 | 22.68 | -1.35% | 536,257 |
Delayed Quote Nasdaq, June 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.72% | 2.08B | |
+17.73% | 124B | |
+16.88% | 111B | |
-9.04% | 23.17B | |
+4.43% | 22.94B | |
-38.15% | 17.42B | |
-7.75% | 17.42B | |
-15.59% | 16.9B | |
+3.42% | 13.71B | |
+29.63% | 11.82B |
- Stock Market
- Equities
- RCKT Stock